SecBot SecBot
6-K ·Filed Jul 28, 2026

OPTH

Optimi Health Corp.
NEUTRAL
Impact 3/10
Horizonweeks Processed3mo ago SEC0001213900-26-082397
Actionable Insight • Neutral

This is a routine governance filing with no immediate trading catalyst. Monitor the August 13 meeting outcome for preferred share authorization, which could enable future capital raises but carries no current terms. The next material event to watch is the company's next quarterly earnings or operational update.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
OPTH ▼ -29.76% at T+60d
NEUTRAL call -29.76% · α vs SPY -34.49% · entry $4.67 → $3.28
Entry = T+0 close
Jul 28, 2026
via day close
T+1d
+0.43%
call +0.43% · α -1.25%
$4.69
settled 3mo ago
T+5d
+8.14%
call +8.14% · α +2.61%
$5.05
settled 3mo ago
T+20d
+4.93%
call +4.93% · α -0.10%
$4.90
settled 2mo ago
T+60d
-29.76%
call -29.76% · α -34.49%
$3.28
settled 6d ago

Price Chart

Loading chart...

Executive Summary

Optimi Health Corp. filed its annual meeting proxy materials, including a management information circular and forms of proxy, for its August 13, 2026 Annual General and Special Meeting. The circular discloses executive compensation for FY2025 (total compensation ranging from $17,234 to $165,000 for named officers), details a routine 15% rolling equity incentive plan amendment, and proposes a special resolution to create 'blank cheque' preferred shares for future financing flexibility. The filing is a routine governance and administrative update with no material financial data or operational catalysts.

Key Facts

  • Annual General and Special Meeting scheduled for August 13, 2026.
  • Shareholders to vote on fixing the board at six directors, electing five nominees, and appointing Davidson & Company LLP as auditor.
  • Proposal to ratify an amended and restated 15% rolling equity incentive plan (administrative/clerical changes, no increase in share reserve).
  • Special resolution to create a class of 'blank cheque' preferred shares, issuable in series, for future capital-raising flexibility.
  • Executive compensation for FY2025: Dane Stevens (CEO/CMO) $75,000; Jacob Safarik (Interim CFO) $150,000; Bryan Safarik (COO) $150,000; JJ Wilson (Chair) $165,000.
  • As of the record date (July 6, 2026), there were 5,725,867 common shares outstanding.
  • No beneficial owners with >10% of outstanding voting rights were identified.
  • The company ceased to be a 'venture issuer' under Canadian securities law effective May 20, 2026.

Financial Impact

No material financial impact from this routine proxy filing. Executive compensation totals are disclosed but unchanged from prior year patterns. The preferred share authorization is a blank-cheque structure with no immediate issuance or terms set.

Risk Factors

  • Preferred share authorization, if passed, gives the board broad discretion to issue a new class of securities with terms that could dilute common shareholders or alter capital structure.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 8 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (OPTH) — Batch item 10001213900-26-082397
Document: ea0299421-6k_optimi.htm0001213900-26-082397
Document: ea029942101ex99-3.htm0001213900-26-082397
Document: ea029942101ex99-2.htm0001213900-26-082397
Document: 0001213900-26-082397-index-headers.html0001213900-26-082397
Document: 0001213900-26-082397-index.html0001213900-26-082397
Document: 0001213900-26-082397.txt0001213900-26-082397
6-K Filing (OPTH) — Batch item 80001213900-26-082397
24 reports for OPTH
Performance horizon
30% Hit rate @ T+5 3 of 10 directional calls Went positive at some point 4 of 10 best @ T+5▲ +10.22%Sep 10, 2026
Filters
Rows
Reports for OPTH — sortable, filterable
TypeNow
Oct 26, 2026
today
6-K
NEUTRAL ★ 3/10
$3.36awaiting T+5—$3.12 (−7.14%)
Oct 20, 2026
6d ago
6-K
NEUTRAL ★ 4/10
$3.36awaiting T+5—$3.12 (−7.14%)
Oct 7, 2026
19d ago
6-K
NEUTRAL ★ 2/10
$4.04 $3.17▼ −21.66%▼ −20.68%$3.12 (−22.77%)
Oct 5, 2026
21d ago
SC 13G/A
NEUTRAL ★ 3/10
$4.13 $3.50▼ −15.25%▼ −15.12%$3.12 (−24.46%)
Sep 29, 2026
27d ago
6-K
NEUTRAL ★ 2/10
$4.78 $4.13▼ −13.60%▼ −15.55%$3.12 (−34.73%)
Sep 23, 2026
4w ago
6-K
NEUTRAL ★ 3/10
$4.96 $4.71▼ −5.04%▼ −4.37%$3.12 (−37.10%)
Sep 22, 2026
4w ago
6-K
NEUTRAL ★ 3/10
$4.96 $4.78▼ −3.63%▼ −2.44%$3.12 (−37.10%)
Sep 16, 2026
5w ago
6-K
BULLISH ★ 6/10
$4.90 $4.96▲ +1.22%▼ −0.60%$3.12 (−36.33%)
Sep 10, 2026
6w ago
6-K
BULLISH ★ 5/10
$4.50 $4.96▲ +10.22%▲ +10.72%$3.12 (−30.67%)
Aug 26, 2026
8w ago
6-K
BEARISH ★ 6/10
$4.89 $4.70▲ +3.89%▲ +4.15%$3.12 (+36.20%)
Showing 10 of 24

US Market Status

Market Closed — Opens Wed (11h 22m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 28, 2026